Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Oncogene

• Publication date

  1998-04-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1201752PMID 9619832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FEBS Lett

  2000cited by this paper
• Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

  1997cited by this paper
• Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

  1997cited by this paper
• Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl

  1997cited by this paper
• From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair

  1997cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

  1997cited by this paper
• A superfamily of conserved domains in DNA damage‐ responsive cell cycle checkpoint proteins

  1997cited by this paper
• Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region

  1997cited by this paper
• A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells.

  1997cited by this paper
• The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

  1996cited by this paper
• BRCA1 protein products ... Functional motifs...

  1996cited by this paper
• Induction of apoptosis by the tumor suppressor protein BRCA1.

  1996cited by this paper
• Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells.

  1996cited by this paper
• p202, an Interferon-inducible Modulator of Transcription, Inhibits Transcriptional Activation by the p53 Tumor Suppressor Protein, and a Segment from the p53-binding Protein 1 That Binds to p202 Overcomes This Inhibition*

  1996cited by this paper
• Evidence for a transcriptional activation function of BRCA1 C-terminal region.

  1996cited by this paper
• The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M

  1996cited by this paper
• Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2

  1996cited by this paper
• BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.

  1996cited by this paper
• BRCA1 is secreted and exhibits properties of a granin

  1996cited by this paper
• Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts.

  1996cited by this paper
• Transcriptional activation by BRCA1

  1996cited by this paper
• BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen.

  1996cited by this paper
• Location of BRCA1 in Human Breast and Ovarian Cancer Cells

  1996cited by this paper
• Growth retardation and tumour inhibition by BRCA1

  1996cited by this paper
• BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.

  1996cited by this paper
• Functional interaction between p53, the TATA-binding protein (TBP), andTBP-associated factors in vivo

  1996cited by this paper
• Subcellular Localization and Analysis of Apparent 180-kDa and 220-kDa Proteins of the Breast Cancer Susceptibility Gene, BRCA1*

  1996cited by this paper
• Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.

  1995cited by this paper
• Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53

  1995cited by this paper
• Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

  1995cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2

  1994cited by this paper
• Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair.

  1993cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper
• Oncogenic forms of p53 inhibit p53-regulated gene expression.

  1992cited by this paper
• Tumor necrosis factor stimulates epithelial tumor cell motility.

  1991cited by this paper
• Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

  1988cited by this paper

• Dss1 facilitates Rad51 recruitment downstream of BRCA2/Brh2 in response to DNA damage.

  2026cites this paper
• BRCA1 and BRCA2 gene expression: p53- and cell cycle-dependent repression requires RB and DREAM

  2025influential citation
• Ferritinophagy-mediated apoptosis and paraptosis induction involved MAPK and PI3K/AKT pathway in mechanism of an iron chelator.

  2023cites this paper
• DNA damage, cell cycle perturbation and cell death by naphthalene diimide derivative in gastric cancer cells.

  2022cites this paper
• Effects of

  2022cites this paper
• Decoding Breast Cancer Metabolism: Hunting BRCA Mutations by Raman Spectroscopy

  2022cites this paper
• The application of Raman spectroscopy and chemometric methods for analysis healthy blood and blood with BRCA mutation

  2022cites this paper
• PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer.

  2022cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• Effects of H19/SAHH/DNMT1 on the oxidative DNA damage related to benzo[a]pyrene exposure

  2021cites this paper
• In utero exposure to chlordecone affects histone modifications and activates LINE-1 in cord blood

  2021cites this paper
• Brca2 deficiency drives gastrointestinal tumor formation and is selectively inhibited by mitomycin C

  2020cites this paper
• OGG1 methylation mediated the effects of cell cycle and oxidative DNA damage related to PAHs exposure in Chinese coke oven workers.

  2019cites this paper
• Downregulation of c-Myc and p21 expression and induction of S phase arrest by naphthalene diimide derivative in gastric adenocarcinoma cells.

  2019cites this paper
• Effects of Breast Cancer Genes 1 and 2 on Cardiovascular Diseases.

  2019cites this paper
• Induction of HRR genes and inhibition of DNMT1 is associated with anthracycline anti-tumor antibiotic-tolerant breast carcinoma cells

  2018cites this paper
• Studies of Breast Cancer Chemoprevention in Human High-Risk Primary Cells and Genetically Engineered Mouse Models

  2018cites this paper
• Ubiquitin Protein Ligase Ring2 Is Involved in S‐phase Checkpoint and DNA Damage in Cells Exposed to Benzo[a]pyrene

  2016cites this paper
• Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1–miR-593-5p–MFF axis

  2015cites this paper
• Functional Genomics Screening Utilizing Mutant Mouse Embryonic Stem Cells Identifies Novel Radiation-Response Genes

  2015cites this paper
• Title Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA 1-miR-593-5 p-MFF axis

  2015cites this paper
• Effect of adriamycin on BRCA 1 and PARP-1 expression in MCF-7 breast cancer cells

  2014cites this paper
• Effect of adriamycin on BRCA1 and PARP-1 expression in MCF-7 breast cancer cells.

  2014cites this paper
• ERK1/2 Signaling Plays an Important Role in Topoisomerase II Poison-Induced G2/M Checkpoint Activation

  2012cites this paper
• Rol de BRCA1 en la regulación de la transcripción en cáncer de próstata

  2011cites this paper
• Molecular and Cellular Pathobiology Cancer Research Transcriptional Autoregulation by BRCA 1

  2010cites this paper
• Transcriptional autoregulation by BRCA1.

  2010cites this paper
• BP1, an Isoform of DLX4 Homeoprotein, Negatively Regulates BRCA1 in Sporadic Breast Cancer

  2010influential citation
• Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1

  2010cites this paper
• Transcriptional Autoregulation by BRCA 1

  2010cites this paper
• Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.

  2010cites this paper
• Transcriptional regulation of BRCA1 expression by a metabolic switch

  2010cites this paper
• Enhancing the efficacy of platinum-based chemotherapeutics by targeting BRCA1

  2010cites this paper
• High-Mobility Group A (HMGA) Proteins and Breast Cancer

  2010cites this paper
• Altered Expression of Proliferation-Inducing and Proliferation-Inhibiting Genes Might Contribute to Acquired Doxorubicin Resistance in Breast Cancer Cells

  2009cites this paper
• Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas

  2009cites this paper
• BRCA1 and Tip60 determine the cellular response to ultraviolet irradiation through distinct pathways

  2008cites this paper
• Novel BRCA2‐interacting protein BJ‐HCC‐20A inhibits the induction of apoptosis in response to DNA damage

  2008cites this paper
• E2F6 negatively regulates ultraviolet-induced apoptosis via modulation of BRCA1

  2007influential citation
• Molecular genetic analysis of the BRCA2 tumor suppressor gene region in cutaneous squamous cell carcinomas

  2007cites this paper
• Difference of cell cycle arrests induced by lidamycin in human breast cancer cells

  2006cites this paper
• Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC

  2006cites this paper
• BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells

  2006cites this paper
• BRCA 1 and BRCA 2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells

  2006cites this paper
• A Molecular Model For Transcriptional Regulation of BRCA-1 Expression

  2005cites this paper
• Model of transcriptional regulation of the BRCA1-NBR2 bi-directional transcriptional unit.

  2005cites this paper
• Development and applications of a real-time quantitative RT-PCR method (QRT-PCR) for BRCA1 mRNA.

  2005cites this paper
• HMGA1 protein expression sensitizes cells to cisplatin-induced cell death

  2005cites this paper
• Liriodenine inhibits the proliferation of human hepatoma cell lines by blocking cell cycle progression and nitric oxide-mediated activation of p53 expression.

  2005cites this paper
• BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA Damage

  2004cites this paper
• Mutagen Sensitivity of Human Lymphoblastoid Cells with a BRCA1 Mutation

  2003cites this paper
• Role of BRCA1 in heat shock response

  2003cites this paper
• p53 Mediates Repression of the BRCA2 Promoter and Down-regulation of BRCA2 mRNA and Protein Levels in Response to DNA Damage*

  2003cites this paper
• BRCA1 gene in breast cancer

  2003influential citation
• Molecular interactions between endogenous and exogenous factors: Regulation of BRCA-1 tumor suppressor gene expression in breast cancer cells

  2003cites this paper
• p300 Modulates the BRCA1 inhibition of estrogen receptor activity.

  2002cites this paper
• Activation of the aromatic hydrocarbon receptor pathway is not sufficient for transcriptional repression of BRCA-1: requirements for metabolism of benzo[a]pyrene to 7r,8t-dihydroxy-9t,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.

  2002cites this paper
• Changes in BRCA1 and BRCA2 expression produced by chemotherapeutic agents in human breast cancer cells.

  2002cites this paper
• Epigenetics of breast cancer: Polycyclic aromatic hydrocarbons as risk factors

  2002cites this paper
• Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell line.

  2002cites this paper
• Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related?

  2002cites this paper
• BRCA-1, BRCA-2 and Hereditary Breast Cancer

  2002cites this paper
• BRCA1 and Prostate Cancer

  2001cites this paper
• The vitamin D3 analog, ILX-23-7553, enhances the response to Adriamycin and irradiation in MCF-7 breast tumor cells

  2001cites this paper
• Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

  2001cites this paper
• Advances in Brief Ultraviolet Irradiation Induces BRCA 2 Protein Depletion through a p 53-independent and Protein Synthesis-dependent Pathway 1

  2001cites this paper
• Regulation of BRCA1 and BRCA2 transcript in response to cisplatin, adriamycin, taxol and ionising radiation is correlated to p53 functional status in ovarian cancer cell lines.

  2001cites this paper
• Spanish family study on hereditary breast and/or ovarian cancer: Analysis of the BRCA1 gene

  2001cites this paper
• Spanish family study on hereditary breast and/or ovarian cancer: analysis of the BRCA1 gene.

  2001cites this paper
• Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway

  2001cites this paper
• Ultraviolet irradiation induces BRCA2 protein depletion through a p53-independent and protein synthesis-dependent pathway.

  2001cites this paper
• Breast cancer-predisposing genes in Finnish breast and ovarian cancer families

  2001cites this paper
• Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1

  2001cites this paper
• Identification of a novel transcriptional repressor element located in the first intron of the human BRCA1 gene

  2001cites this paper
• Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage

  2000cites this paper
• Proliferation-Associated Expression of the MEN1 Gene as Revealed by In Situ Hybridization: Possible Role of the Menin as a Negative Regulator of Cell Proliferation Under DNA Damage

  2000cites this paper
• The vitamin D3 analog EB 1089 enhances the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells

  2000cites this paper
• Roles of BRCA1 and its interacting proteins

  2000cites this paper
• Increased sensitivity to chromatid aberration induction by bleomycin and neocarzinostatin results from alterations in a DNA damage response pathway.

  2000cites this paper
• Biological Basis of Radiation Sensitivity

  2000cites this paper
• Disruption of cell cycle kinetics by benzo[a]pyrene: inverse expression patterns of BRCA-1 and p53 in MCF-7 cells arrested in S and G2.

  2000cites this paper
• Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation.

  2000cites this paper
• BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1.

  2000cites this paper
• Repression of BRCA1 through a Feedback Loop Involving p53*

  2000cites this paper
• Kinetics of BRCA1 regulation in response to UVC radiation

  2000cites this paper
• P53-independent down-regulation of Mdm2 in human cancer cells treated with adriamycin.

  2000cites this paper
• Biological basis of radiation sensitivity. Part 2: Cellular and molecular determinants of radiosensitivity.

  2000cites this paper
• The Functions of Breast Cancer Susceptibility Gene 1 (BRCA1) Product and Its Associated Proteins

  1999cites this paper
• Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.

  1999cites this paper
• Inhibition of BRCA‐1 expression by benzo[a]pyrene and its diol epoxide

  1999cites this paper
• BRCA1, BRCA2 and their possible function in DNA damage response

  1999cites this paper
• Characterization of the MEN1 Gene Product, Menin, by Site‐specific Polyclonal Antibodies

  1999cites this paper
• Regulation of BRCA1 by protein degradation

  1999cites this paper
• Molecular biology in radiation oncology. Radiation oncology perspective of BRCA1 and BRCA2.

  1999cites this paper
• Differential effects of chemotherapeutic agents on the Bcl‐2/Bax apoptosis pathway in human breast cancer cell line MCF‐7

  1999cites this paper
• Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells

  1999cites this paper
• Down‐regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation

  1998cites this paper
• Women's Health LiteratureWatch & Commentary

  1998cites this paper
• Inherited breast cancer: an emerging picture

  1998cites this paper
• Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress

  1998cites this paper